Effects of a Novel Infant Formula on the Fecal Microbiota in the First Six months of Life: The INNOVA 2020 Study
Metadatos
Mostrar el registro completo del ítemEditorial
MDPI
Materia
Arachidonic acid alpha-lactalbumin Bifidobacterium animalis subsp. lactis Body composition Docosahexaenoic acid Postbiotics
Fecha
2023-02-03Referencia bibliográfica
Ruiz-Ojeda, F.J... [et al.]. Effects of a Novel Infant Formula on the Fecal Microbiota in the First Six months of Life: The INNOVA 2020 Study. Int. J. Mol. Sci. 2023, 24, 3034. [https://doi.org/10.3390/ijms24033034]
Patrocinador
Alter Farmacia S. AResumen
Exclusive breastfeeding is highly recommended for infants for at least the first six months
of life. However, for some mothers, it may be difficult or even impossible to do so. This can lead
to disturbances in the gut microbiota, which in turn may be related to a higher incidence of acute
infectious diseases. Here, we aimed to evaluate whether a novel starting formula versus a standard
formula provides a gut microbiota composition more similar to that of breastfed infants in the first
6 months of life. Two hundred and ten infants (70/group) were enrolled in the study and completed
the intervention until 12 months of age. For the intervention period, infants were divided into three
groups: Group 1 received formula 1 (INN) with a lower amount of protein, a proportion of casein to
whey protein ratio of about 70/30 by increasing the content of -lactalbumin, and with double the
amount of docosahexaenoic acid/arachidonic acid than the standard formula; INN also contained a
thermally inactivated postbiotic (Bifidobacterium animalis subsp. lactis). Group 2 received the standard
formula (STD) and the third group was exclusively breastfed (BF) for exploratory analysis. During
the study, visits were made at 21 days, 2, 4, and 6 months of age, with 3 days for the visit at
21 days of age, 1 week for the visit at 2 months, and 2 weeks for the others. Here, we reveal
how consuming the INN formula promotes a similar gut microbiota composition to those infants
that were breastfed in terms of richness and diversity, genera, such as Bacteroides, Bifidobacterium,
Clostridium, and Lactobacillus, and calprotectin and short-chain fatty acid levels at 21 days, 2 and
6 months. Furthermore, we observed that the major bacteria metabolic pathways were more alike
between the INN formula and BF groups compared to the STD formula group. Therefore, we assume
that consumption of the novel INN formula might improve gut microbiota composition, promoting a
healthier intestinal microbiota more similar to that of an infant who receives exclusively human milk.